Therapeutic Fc fusion protein misfolding: A three-phasic cultivation experimental design
- PMID: 30650123
- PMCID: PMC6334962
- DOI: 10.1371/journal.pone.0210712
Therapeutic Fc fusion protein misfolding: A three-phasic cultivation experimental design
Abstract
Cell culture process optimization is a critical solution to most of the challenges faced by the pharmaceutical manufacturing. One of the major problems encountered in large-scale production of therapeutic proteins is misfolded protein production. The accumulation of misfolded therapeutic proteins is an immunogenic signal and a risk factor for immunogenicity of the final product. The aim of this study was the statistical optimization of three-phasic temperature shift and timing for enhanced production of correctly folded Fc-fusion protein. The effect of culture temperatures were investigated using the biphasic culture system. Box-Behnken design was then used to compute temperature and time of shifting optimum. Response surface methodology revealed that maximum production with low level of misfolded protein was achieved at two-step temperature shift from 37°C to 30°C during the late logarithmic phase and 30°C to 28°C in the mid-stationary phase. The optimized condition gave the best results of 1860 mg L-1 protein titer with 24.5% misfolding level. The validation experiments were carried out under optimal conditions with three replicates and the protein misfolding level was decreased by two times while productivity increased by ~ 1.3-fold. Large-scale production in 250 L bioreactor under the optimum conditions was also verified the effectiveness and the accuracy of the model. The results showed that by utilizing two-step temperature shift, productivity and the quality of target protein have been improved simultaneously. This model could be successfully applied to other products.
Conflict of interest statement
The authors confirm that the commercial affiliation to Aryogen Pharmed Inc. does not alter our adherence to PLOS ONE policies on sharing data and materials.
Figures




Similar articles
-
Multivariate Optimization of the Refolding Process of an Incorrectly Folded Fc-Fusion Protein in a Cell Culture Broth.Curr Pharm Biotechnol. 2020;21(3):226-235. doi: 10.2174/1389201020666191002144424. Curr Pharm Biotechnol. 2020. PMID: 31577202
-
The Effect of Culture Temperature on the Aggregation of Recombinant TNFR-Fc is Regulated by the PERK-eIF2a Pathway in CHO Cells.Protein Pept Lett. 2018;25(6):570-579. doi: 10.2174/0929866525666180530121317. Protein Pept Lett. 2018. PMID: 29848262
-
Process parameter shifting: Part II. Biphasic cultivation-A tool for enhancing the volumetric productivity of batch processes using Epo-Fc expressing CHO cells.Biotechnol Bioeng. 2006 Aug 20;94(6):1045-52. doi: 10.1002/bit.20958. Biotechnol Bioeng. 2006. PMID: 16736532
-
Process parameter shifting: Part I. Effect of DOT, pH, and temperature on the performance of Epo-Fc expressing CHO cells cultivated in controlled batch bioreactors.Biotechnol Bioeng. 2006 Aug 20;94(6):1033-44. doi: 10.1002/bit.21013. Biotechnol Bioeng. 2006. PMID: 16736530
-
Integrated cell and process engineering for improved transient production of a "difficult-to-express" fusion protein by CHO cells.Biotechnol Bioeng. 2015 Dec;112(12):2527-42. doi: 10.1002/bit.25687. Epub 2015 Sep 7. Biotechnol Bioeng. 2015. PMID: 26126657
Cited by
-
Impact of SARS-CoV-2 RBD Mutations on the Production of a Recombinant RBD Fusion Protein in Mammalian Cells.Biomolecules. 2022 Aug 24;12(9):1170. doi: 10.3390/biom12091170. Biomolecules. 2022. PMID: 36139010 Free PMC article.
-
A Computational Approach to Modeling an Antagonistic Angiogenic VEGFR1-IL2 Fusion Protein for Cancer Therapy.Bioinform Biol Insights. 2021 Sep 20;15:11779322211043297. doi: 10.1177/11779322211043297. eCollection 2021. Bioinform Biol Insights. 2021. PMID: 34566410 Free PMC article.
References
-
- Berger S, Lowe P, Tesar M. Fusion protein technologies for biopharmaceuticals: Applications and challenges: Editor Stefan R Schmidt. mAbs. 2015;7(3): 456–60.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources